Can ondansetron (Zofran) be given to a patient taking bupropion (Wellbutrin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Ondansetron (Zofran) Be Given with Bupropion (Wellbutrin)?

Yes, ondansetron can be safely given to patients taking bupropion—there is no contraindication or clinically significant drug interaction between these medications.

Key Safety Considerations

The FDA drug label for bupropion (Wellbutrin) does not list ondansetron as a contraindicated medication or problematic drug interaction 1. The primary drug interaction concerns with bupropion involve:

  • MAO inhibitors (contraindicated due to hypertensive crisis risk)
  • Drugs metabolized by CYP2D6 (bupropion inhibits this enzyme)
  • Medications that lower seizure threshold (requires caution with antipsychotics, other antidepressants, theophylline, systemic corticosteroids)
  • Dopaminergic drugs like levodopa and amantadine (CNS toxicity risk)

Ondansetron does not fall into any of these problematic categories 1.

Clinical Context from Guidelines

Multiple clinical practice guidelines recommend ondansetron for various indications without any warnings about bupropion co-administration:

  • ASCO antiemetic guidelines extensively detail ondansetron dosing for chemotherapy-induced nausea/vomiting with no mention of bupropion interactions 2, 3
  • NCCN smoking cessation guidelines discuss both bupropion (for smoking cessation) and ondansetron separately without contraindication warnings 4
  • AGA pregnancy guidelines recommend ondansetron for hyperemesis gravidarum as second-line therapy without bupropion interaction concerns 5

Theoretical Pharmacologic Considerations

While one older study suggested that SSRI antidepressants (specifically fluoxetine) might theoretically reduce ondansetron's antiemetic efficacy through serotonin reuptake inhibition competing at 5-HT3 receptors 6, this concern does not apply to bupropion. Bupropion is a norepinephrine-dopamine reuptake inhibitor, not a serotonin reuptake inhibitor 7. It does not affect serotonin pathways in a way that would interfere with ondansetron's 5-HT3 receptor antagonism.

Practical Prescribing Guidance

You can prescribe ondansetron to patients on bupropion without dose adjustments or special monitoring beyond standard precautions for each medication individually:

  • Monitor for bupropion's seizure risk (especially with doses >450 mg/day, history of eating disorders, alcohol withdrawal) 1
  • Monitor for ondansetron's common side effects (headache, constipation, potential QT prolongation at high doses)
  • No specific drug-drug interaction monitoring is required

The combination is commonly used in clinical practice, particularly in oncology patients receiving chemotherapy who may also be treated with bupropion for depression or smoking cessation 4, 2, 3.

References

Guideline

antiemetics: asco guideline update.

Journal of Clinical Oncology, 2020

Guideline

smoking cessation, version 1.2016, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

Research

Fluoxetine treatment comprises the antiemetic efficacy of ondansetron in cancer patients.

Clinical oncology (Royal College of Radiologists (Great Britain)), 1995

Guideline

american association of clinical endocrinologists and american college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2016

Related Questions

What are the drug interactions and safety considerations when combining Aciphex (rabeprazole) with fluoxetine?
Can Amlodipine (calcium channel blocker) and Zoloft (sertraline, selective serotonin reuptake inhibitor) be used together?
Are there any contraindications or drug interactions when adding amoxicillin to a regimen that includes levothyroxine, mupirocin, potassium chloride (Klor‑Con), hydrochlorothiazide, losartan (Cozaar), cyanocobalamin, low‑dose aspirin, rosuvastatin (Crestor), metronidazole topical cream, fluocinonide topical gel, ketoconazole shampoo, hydrocortisone cream, vitamin D3, probiotic (Culturelle), milk‑thistle, melatonin, loratadine (Claritin), propranolol, prazosin, alprazolam (Xanax), amphetamine/dextroamphetamine (Adderall), lamotrigine, escitalopram, buspirone, and oxcarbazepine (Trileptal)?
What clinically significant drug interactions should be considered among duloxetine (Cymbalta), trazodone hydrochloride, propranolol, pregabalin, folic acid, amphetamine‑dextroamphetamine, and amlodipine besylate?
What is the appropriate next step in management for a 25‑year‑old female patient who has been taking levosulpiride 50 mg once daily, escitalopram (Mor­cet) 5 mg at night, propranolol 10 mg twice daily, and alprazolam 0.0625 mg three times daily for two weeks, with modest symptom improvement but now experiencing health‑related anxiety, fear of salt and sweets, and excessive rumination?
What is the appropriate dose of lorazepam for treating a seizure?
What alternative oral therapies can be used for a patient with an E. coli urinary tract infection resistant to trimethoprim‑sulfamethoxazole (Bactrim), allergic to penicillins, and not responding to nitrofurantoin?
What is the clinical significance of a vitamin B12 level of 1291 pg/mL and a folate level of 4.5 ng/mL?
After a 2500 µg methylcobalamin injection, how many days should elapse before the next dose?
Is naproxen safe for pain management in a patient with pancreatitis?
What is the optimal acute and prophylactic treatment for a patient with migraine who also has altered gastrointestinal motility (e.g., constipation or diarrhea)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.